MDMA alters emotional processing and facilitates positive social interaction

[1]  Christoph Eisenegger,et al.  MDMA enhances emotional empathy and prosocial behavior. , 2014, Social cognitive and affective neuroscience.

[2]  M. Liechti,et al.  Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. , 2014, The international journal of neuropsychopharmacology.

[3]  Charles G. Frye,et al.  MDMA decreases the effects of simulated social rejection , 2014, Pharmacology, Biochemistry and Behavior.

[4]  Harriet de Wit,et al.  Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing , 2014, Neuropsychopharmacology.

[5]  H. de Wit,et al.  In the company of others: social factors alter acute alcohol effects , 2013, Psychopharmacology.

[6]  T. Brewerton,et al.  Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study , 2013, Journal of psychopharmacology.

[7]  U. Schnyder,et al.  A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) , 2013, Journal of psychopharmacology.

[8]  M. Munafo,et al.  Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior , 2012, Psychopharmacology.

[9]  M. Wardle,et al.  Effects of amphetamine on reactivity to emotional stimuli , 2012, Psychopharmacology.

[10]  M. Liechti,et al.  MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions , 2012, Psychopharmacology.

[11]  C. Montag,et al.  The influence of alcohol intake and alcohol expectations on the recognition of emotions. , 2011, Alcohol and alcoholism.

[12]  L. Jerome,et al.  The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study , 2011, Journal of Psychopharmacology (Oxford, England).

[13]  M. Wardle,et al.  Quantifying talk: developing reliable measures of verbal productivity , 2011, Behavior research methods.

[14]  Harriet de Wit,et al.  Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others , 2010, Biological Psychiatry.

[15]  Sunjeev K Kamboj,et al.  Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions. , 2010, Drug and alcohol dependence.

[16]  Jennifer S. Pardo,et al.  Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech , 2010, Psychopharmacology.

[17]  M. Angstadt,et al.  Effects of MDMA on sociability and neural response to social threat and social reward , 2009, Psychopharmacology.

[18]  PØ Johansen,et al.  How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale , 2009, Journal of psychopharmacology.

[19]  Catherine J. Harmer,et al.  Serotonin and emotional processing: Does it help explain antidepressant drug action? , 2008, Neuropharmacology.

[20]  M. Farré,et al.  MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder , 2008, Journal of psychoactive drugs.

[21]  P. Petrovic,et al.  Emotional perception modulated by an opioid and a cholecystokinin agonist , 2008, Psychopharmacology.

[22]  S. G. Nikolov,et al.  Turning the other cheek: the viewpoint dependence of facial expression after-effects , 2007, Proceedings of the Royal Society B: Biological Sciences.

[23]  D. McIntosh,et al.  More than mere mimicry? The influence of emotion on rapid facial reactions to faces. , 2007, Emotion.

[24]  M. Tancer,et al.  The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans , 2006, Psychopharmacology.

[25]  A. Parrott,et al.  Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors , 2006, Journal of psychopharmacology.

[26]  Jon C. Cole,et al.  The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy , 2006, Journal of psychopharmacology.

[27]  Simon J Graham,et al.  Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. , 2005, Archives of general psychiatry.

[28]  Tom F M ter Bogt,et al.  “Partying” Hard: Party Style, Motives for and Effects of MDMA Use at Rave Parties , 2005, Substance use & misuse.

[29]  D. Janowsky.  Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: Effects of antidepressants, amphetamine, and methylphenidate , 2003, Current psychiatry reports.

[30]  K. LaBar,et al.  Functional Magnetic Resonance Imaging (fmri) Was Used to Compare Brain Activation to Static Facial Displays versus Dynamic Changes in Facial Identity or Emotional Expression. Static Images Depicted Prototypical Fearful, Angry and Neutral Expressions. Identity Morphs Depicted Identity Changes from On , 2022 .

[31]  Jeff T. Larsen,et al.  Effects of positive and negative affect on electromyographic activity over zygomaticus major and corrugator supercilii. , 2003, Psychophysiology.

[32]  R. Griffiths,et al.  Principles of initial experimental drug abuse liability assessment in humans. , 2003, Drug and alcohol dependence.

[33]  F. Gabbay.  Variations in affect following amphetamine and placebo: markers of stimulant drug preference. , 2003, Experimental and clinical psychopharmacology.

[34]  H. Wit,et al.  Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase , 2002, Pharmacology Biochemistry and Behavior.

[35]  H. Wittchen,et al.  Mental disorders in ecstasy users: a prospective-longitudinal investigation. , 2002, Drug and alcohol dependence.

[36]  J. Mendelson,et al.  Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans , 2002, Psychopharmacology.

[37]  F. Vollenweider,et al.  Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies , 2001, Human psychopharmacology.

[38]  F. Vollenweider,et al.  Gender differences in the subjective effects of MDMA , 2001, Psychopharmacology.

[39]  U. Dimberg,et al.  Unconscious Facial Reactions to Emotional Facial Expressions , 2000, Psychological science.

[40]  F. Vollenweider,et al.  Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers , 1998, Neuropsychopharmacology.

[41]  U. Dimberg,et al.  Facial reactions to different emotionally relevant stimuli , 1997 .

[42]  L. Judd,et al.  Interpersonal effects of marijuana. A model for the study of interpersonal psychopharmacology. , 1979, Archives of general psychiatry.

[43]  William H. Meller,et al.  PSYCHOPHARMACOLOGY , 1957, Ministry with Persons with Mental Illness and Their Families, Second Edition.

[44]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[45]  M. First,et al.  Structured Clinical Interview for DSM-IV Axis I Disorders , 1997 .

[46]  P. Cowen,et al.  Increased Positive versus Negative Affective Perception and Memory in Healthy Volunteers following Selective Serotonin and Norepinephrine Reuptake Inhibition , 2022 .